Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
capsule formulation
Description:
The development of pharmaceutical products in capsule dosage form, including selection of ingredients and evaluation of drug release or bioavailability.
Related topics:
Analytical Methods in Pharmaceuticals (19%),
Drug Solubulity and Delivery Systems (12%)
OpenAlex ID:
keywords/capsule-formulation
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
1998
·
E. Galia
, E. Nicolaides
, et al.
·
Pharmaceutical Research
·
1,046
The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers
2002
·
Gary H Kamimori
, Chetan S Karyekar
, et al.
·
International Journal of Pharmaceutics
·
449
The effect of particle size distribution on dissolution rate and oral absorption
1989
·
R HINTZ
, K JOHNSON
·
International Journal of Pharmaceutics
·
364
An encapsulation system for the immunoisolation of pancreatic islets
1997
·
Taylor Wang
, Igor Lacík
, et al.
·
Nature Biotechnology
·
337
Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers
1993
·
J A Barone
, J G Koh
, et al.
·
Antimicrobial Agents and Chemotherapy
·
240
The effect of Momordica charantia capsule preparation on glycemic control in Type 2 Diabetes Mellitus needs further studies
2006
·
Antonio Miguel Limcaco Dans
, Maria Vanessa C. Villarruz
, et al.
·
Journal of Clinical Epidemiology
·
232
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
2006
·
Daniel Coyne
, Muralidhar Acharya
, et al.
·
American Journal of Kidney Diseases
·
232
Enhanced Bioavailability of Itraconazole in Hydroxypropylβ-Cyclodextrin Solution versus Capsules in Healthy Volunteers
1998
·
Joseph A. Barone
, Bruce L. Moskovitz
, et al.
·
Antimicrobial Agents and Chemotherapy
·
226
PDF
Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man
1997
·
G. Flesch
, P. Müller
, et al.
·
European Journal of Clinical Pharmacology
·
219
Absolute Bioavailability of Imatinib (Glivec®) Orally versus Intravenous Infusion
2004
·
Bin Peng
, Catherine Dutreix
, et al.
·
The Journal of Clinical Pharmacology
·
189
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
1989
·
A. Van Peer
, R. Woestenborghs
, et al.
·
European Journal of Clinical Pharmacology
·
187
Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
2012
·
Gopal Krishna
, Lei Ma
, et al.
·
Antimicrobial Agents and Chemotherapy
·
165
PDF
Enhanced Bioavailability of a Poorly Soluble VR1 Antagonist Using an Amorphous Solid Dispersion Approach: A Case Study
2008
·
Michael Kennedy
, Jack Hu
, et al.
·
Molecular Pharmaceutics
·
164
Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis
2003
·
Fumio Takayama
, Kentaro Taki
, et al.
·
American Journal of Kidney Diseases
·
153
Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol–polysorbate 80 solid dispersion carrier system
2004
·
Rose-Marie Dannenfelser
, Handan He
, et al.
·
Journal of Pharmaceutical Sciences
·
146
A Solid-State Approach to Enable Early Development Compounds: Selection and Animsal Bioavailability Studies of an Itraconazole Amorphous Solid Dispersion
2010
·
David Engers
, Jing Teng
, et al.
·
Journal of Pharmaceutical Sciences
·
136
PDF
Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine
1997
·
CH. Lauritzen
, H.D. Reuter
, et al.
·
Phytomedicine
·
133
Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.
1997
·
J D Cartledge
, J Midgely
, et al.
·
Journal of Clinical Pathology
·
125
PDF
A strategy for preclinical formulation development using GastroPlus™ as pharmacokinetic simulation tool and a statistical screening design applied to a dog study
2005
·
Martin Kuentz
, Sonja Nick
, et al.
·
European Journal of Pharmaceutical Sciences
·
119
Pharmacokinetic Interactions with Digoxin
1988
·
Steven M. Rodin
, Brian F. Johnson
·
Clinical Pharmacokinetics
·
113
Development and Evaluation of Controlled-Release Diltiazem HCl Microparticles Using Cross-Linked Poly(Vinyl Alcohol)
1997
·
Dushyant Shah
, Yamini Shah
, et al.
·
Drug Development and Industrial Pharmacy
·
108
GI transit of potential bioadhesive formulations in man: A scintigraphic study
1990
·
D. Harris
, J.T. Fell
, et al.
·
Journal of Controlled Release
·
105
Huperzine-A in capsules and tablets for treating patients with Alzheimer disease.
1999
·
S S Xu
, Z Y Cai
, et al.
·
PubMed
·
98
Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development
2000
·
Michael K. Taylor
, Jeri Ginsburg
, et al.
·
AAPS PharmSciTech
·
97
PDF
Nonlinear assessment of phenytoin bioavailability
1976
·
William J. Jusko
, Jeffrey R. Koup
, et al.
·
Journal of Pharmacokinetics and Biopharmaceutics
·
94
Show more works
View as search
Works count:
2,329
Citation count:
14,570
Year
Topic
Type